Nath Bio-Genes (India) Limited (NATHBIOGEN) - Total Assets

Latest as of March 2026: Rs10.97 Billion INR ≈ $118.68 Million USD

Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) holds total assets worth Rs10.97 Billion INR (≈ $118.68 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Nath Bio-Genes (India) Limited (NATHBIOGEN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Nath Bio-Genes (India) Limited - Total Assets Trend (2012–2026)

This chart illustrates how Nath Bio-Genes (India) Limited's total assets have evolved over time, based on quarterly financial data. Explore Nath Bio-Genes (India) Limited long-term investment intensity to see how much of total assets are deployed in long-term investments.

Nath Bio-Genes (India) Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Nath Bio-Genes (India) Limited's total assets of Rs10.97 Billion consist of 71.0% current assets and 29.0% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 6.9%
Accounts Receivable Rs854.15 Million 7.8%
Inventory Rs4.51 Billion 41.1%
Property, Plant & Equipment Rs0.00 0.0%
Intangible Assets Rs55.86 Million 0.5%
Goodwill Rs0.00 0.0%

Asset Composition Trend (2012–2026)

This chart illustrates how Nath Bio-Genes (India) Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Nath Bio-Genes (India) Limited (NATHBIOGEN) total market value.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Nath Bio-Genes (India) Limited's current assets represent 71.0% of total assets in 2026, a decrease from 80.2% in 2012.
  • Cash Position: Cash and equivalents constituted 6.9% of total assets in 2026, up from 2.7% in 2012.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
  • Asset Diversification: The largest asset category is inventory at 41.1% of total assets.

Nath Bio-Genes (India) Limited Competitors by Total Assets

Key competitors of Nath Bio-Genes (India) Limited based on total assets are shown below.

Company Country Total Assets
Chambal Fertilizers & Chemicals Limited
NSE:CHAMBLFERT
India Rs138.53 Billion
Stanley Fertilizer Co Ltd
SHE:002588
China CN¥15.67 Billion
Kaveri Seed Company Limited
NSE:KSCL
India Rs26.42 Billion
Insecticides (India) Limited
NSE:INSECTICID
India Rs19.97 Billion
Boa Safra Sementes S.A
SA:SOJA3
Brazil R$3.46 Billion
Nongwoobio Co. Ltd
KQ:054050
Korea ₩344.76 Billion
Graines Voltz S.A
PA:GRVO
France €168.49 Million
Nusa Palapa Gemilang PT Tbk
JK:NPGF
Indonesia Rp317.06 Billion

Nath Bio-Genes (India) Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.97 1.89 3.03
Quick Ratio 0.83 0.96 1.72
Cash Ratio 0.00 0.24 0.00
Working Capital Rs3.84 Billion Rs3.25 Billion Rs3.51 Billion

Nath Bio-Genes (India) Limited - Advanced Valuation Insights

This section examines the relationship between Nath Bio-Genes (India) Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.47
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 6.9%
Total Assets Rs10.97 Billion
Market Capitalization $35.35 Million USD

Valuation Analysis

Below Book Valuation: The market values Nath Bio-Genes (India) Limited's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Nath Bio-Genes (India) Limited's assets grew by 6.9% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Nath Bio-Genes (India) Limited (2012–2026)

The table below shows the annual total assets of Nath Bio-Genes (India) Limited from 2012 to 2026.

Year Total Assets Change
2026-03-31 Rs10.97 Billion
≈ $118.68 Million
+6.94%
2025-03-31 Rs10.26 Billion
≈ $110.98 Million
+16.58%
2024-03-31 Rs8.80 Billion
≈ $95.19 Million
+11.03%
2023-03-31 Rs7.93 Billion
≈ $85.74 Million
+6.86%
2022-03-31 Rs7.42 Billion
≈ $80.23 Million
-6.03%
2021-03-31 Rs7.90 Billion
≈ $85.38 Million
+8.16%
2020-03-31 Rs7.30 Billion
≈ $78.94 Million
+12.98%
2019-03-31 Rs6.46 Billion
≈ $69.87 Million
+13.11%
2018-03-31 Rs5.71 Billion
≈ $61.77 Million
+97.41%
2017-03-31 Rs2.89 Billion
≈ $31.29 Million
+8.49%
2016-03-31 Rs2.67 Billion
≈ $28.84 Million
+17.93%
2015-03-31 Rs2.26 Billion
≈ $24.46 Million
+19.07%
2014-03-31 Rs1.90 Billion
≈ $20.54 Million
+19.99%
2013-03-31 Rs1.58 Billion
≈ $17.12 Million
+31.95%
2012-03-31 Rs1.20 Billion
≈ $12.97 Million
--

About Nath Bio-Genes (India) Limited

NSE:NATHBIOGEN India Agricultural Inputs
Market Cap
$35.35 Million
Rs3.27 Billion INR
Market Cap Rank
#23246 Global
#1287 in India
Share Price
Rs172.01
Change (1 day)
+2.80%
52-Week Range
Rs129.02 - Rs234.84
All Time High
Rs537.81
About

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jow… Read more